MTOR and central nervous system cancer: Interestingly, the combination of alpelisib with pharmacologic mTOR inhibition led to a dramatic and significant decrease in the growth of glioma stem cells.133 In another study, the silencing of mTOR or the treatment of rapamycin in A172 cells resulted in the repression of NSC/progenitor markers in GSCs leading to decreased sphere formation.